Cite Filings / CLDI / 0002109116-26-000003

Feed Companies Filings Check

Sign in

SCHEDULE 13D

Beneficial Ownership Report

Calidi Biotherapeutics, Inc. Filed 2026-03-09 Acc 0002109116-26-000003

Documents 1

SCHEDULE 13D Beneficial Ownership Report , xslSCHEDULE_13D_X01/primary_doc.xml

Around this filing

2026-03-31 SCHEDULE 13D Beneficial Ownership Report
2026-03-11 8-K Material agreement · Unregistered share sale · Other events
2026-03-09 SCHEDULE 13D Beneficial Ownership Report
2026-03-09 424B5 Prospectus
2026-03-06 424B5 Prospectus
2026-03-05 S-3MEF S-3MEF
2024-05-01 SCHEDULE 13D Beneficial Ownership Report

Link to a passage

Paste a passage to link it

At least 12 characters, not counting spaces, so the link points to one passage.

External

SEC EDGAR (opens in new tab)

Loading xslSCHEDULE_13D_X01/primary_doc.xml…

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…